Healthpeak Properties (NYSE:DOC – Get Free Report) had its price objective lifted by equities researchers at Cantor Fitzgerald from $20.00 to $23.00 in a report released on Thursday, Marketbeat reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. Cantor Fitzgerald’s price target points to a potential upside of 7.61% from the stock’s previous close.
DOC has been the topic of a number of other research reports. Citigroup increased their price target on shares of Healthpeak Properties from $17.50 to $20.00 and gave the stock a “neutral” rating in a report on Tuesday, May 12th. Raymond James Financial began coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They set a “market perform” rating for the company. Robert W. Baird upped their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Mizuho increased their target price on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, July 6th. Finally, Weiss Ratings upgraded Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Four analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company’s stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and a consensus target price of $20.97.
Check Out Our Latest Report on Healthpeak Properties
Healthpeak Properties Stock Up 1.3%
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The business had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. During the same quarter in the prior year, the firm posted $0.46 EPS. Healthpeak Properties’s revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, equities analysts predict that Healthpeak Properties will post 1.76 EPS for the current fiscal year.
Insiders Place Their Bets
In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.23% of the company’s stock.
Institutional Trading of Healthpeak Properties
A number of institutional investors and hedge funds have recently modified their holdings of DOC. New York Life Investment Management LLC lifted its stake in Healthpeak Properties by 65.8% during the 4th quarter. New York Life Investment Management LLC now owns 156,086 shares of the real estate investment trust’s stock valued at $2,510,000 after acquiring an additional 61,952 shares in the last quarter. Baillie Gifford & Co. grew its stake in shares of Healthpeak Properties by 613.2% in the 4th quarter. Baillie Gifford & Co. now owns 367,256 shares of the real estate investment trust’s stock worth $5,905,000 after acquiring an additional 315,763 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al grew its stake in shares of Healthpeak Properties by 176.0% in the 4th quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 320,040 shares of the real estate investment trust’s stock worth $5,146,000 after acquiring an additional 204,100 shares in the last quarter. Swedbank AB raised its holdings in shares of Healthpeak Properties by 433.4% in the fourth quarter. Swedbank AB now owns 849,215 shares of the real estate investment trust’s stock valued at $13,655,000 after purchasing an additional 690,000 shares during the last quarter. Finally, HF Advisory Group LLC purchased a new stake in shares of Healthpeak Properties in the fourth quarter valued at about $1,507,000. Institutional investors own 93.57% of the company’s stock.
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
